302 related articles for article (PubMed ID: 34367172)
1. Identification of Disease-Associated Cryptococcal Proteins Reactive With Serum IgG From Cryptococcal Meningitis Patients.
Gressler AE; Volke D; Firacative C; Schnabel CL; Müller U; Krizsan A; Schulze-Richter B; Brock M; Brombacher F; Escandón P; Hoffmann R; Alber G
Front Immunol; 2021; 12():709695. PubMed ID: 34367172
[No Abstract] [Full Text] [Related]
2. Antibodies to the Cryptococcus neoformans capsular glucuronoxylomannan are ubiquitous in serum from HIV+ and HIV- individuals.
Deshaw M; Pirofski LA
Clin Exp Immunol; 1995 Mar; 99(3):425-32. PubMed ID: 7882565
[TBL] [Abstract][Full Text] [Related]
3. Detection of IgM and IgG antibodies to Cryptococcus neoformans proteins in blood donors and HIV patients with active cryptococcosis.
Chai HC; Tay ST
Mycoses; 2009 Mar; 52(2):166-70. PubMed ID: 18643920
[TBL] [Abstract][Full Text] [Related]
4. Quantitative and qualitative differences in the serum antibody profiles of human immunodeficiency virus-infected persons with and without Cryptococcus neoformans meningitis.
Fleuridor R; Lyles RH; Pirofski L
J Infect Dis; 1999 Nov; 180(5):1526-35. PubMed ID: 10515812
[TBL] [Abstract][Full Text] [Related]
5. Antibodies reactive with the cryptococcal capsular polysaccharide glucuronoxylomannan are present in sera from children with and without human immunodeficiency virus infection.
Abadi J; Pirofski La
J Infect Dis; 1999 Sep; 180(3):915-9. PubMed ID: 10438394
[TBL] [Abstract][Full Text] [Related]
6. Vaccination with Recombinant
Specht CA; Lee CK; Huang H; Hester MM; Liu J; Luckie BA; Torres Santana MA; Mirza Z; Khoshkenar P; Abraham A; Shen ZT; Lodge JK; Akalin A; Homan J; Ostroff GR; Levitz SM
mBio; 2017 Nov; 8(6):. PubMed ID: 29184017
[TBL] [Abstract][Full Text] [Related]
7. Antibody response to Cryptococcus neoformans proteins in rodents and humans.
Chen LC; Goldman DL; Doering TL; Pirofski La; Casadevall A
Infect Immun; 1999 May; 67(5):2218-24. PubMed ID: 10225877
[TBL] [Abstract][Full Text] [Related]
8. Cryptococcus neoformans-reactive and total immunoglobulin profiles of human immunodeficiency virus-infected and uninfected Ugandans.
Subramaniam K; French N; Pirofski LA
Clin Diagn Lab Immunol; 2005 Oct; 12(10):1168-76. PubMed ID: 16210479
[TBL] [Abstract][Full Text] [Related]
9. A proteomic-based approach for the identification of immunodominant Cryptococcus neoformans proteins.
Young M; Macias S; Thomas D; Wormley FL
Proteomics; 2009 May; 9(9):2578-88. PubMed ID: 19343717
[TBL] [Abstract][Full Text] [Related]
10. Characterization of two novel cryptococcal mannoproteins recognized by immune sera.
Biondo C; Messina L; Bombaci M; Mancuso G; Midiri A; Beninati C; Cusumano V; Gerace E; Papasergi S; Teti G
Infect Immun; 2005 Nov; 73(11):7348-55. PubMed ID: 16239533
[TBL] [Abstract][Full Text] [Related]
11. Serologic evidence for Cryptococcus neoformans infection in early childhood.
Goldman DL; Khine H; Abadi J; Lindenberg DJ; Pirofski La ; Niang R; Casadevall A
Pediatrics; 2001 May; 107(5):E66. PubMed ID: 11331716
[TBL] [Abstract][Full Text] [Related]
12. Peptide epitopes recognized by a human anti-cryptococcal glucuronoxylomannan antibody.
Zhang H; Zhong Z; Pirofski LA
Infect Immun; 1997 Apr; 65(4):1158-64. PubMed ID: 9119446
[TBL] [Abstract][Full Text] [Related]
13. Association Between Plasma Antibody Responses and Risk for Cryptococcus-Associated Immune Reconstitution Inflammatory Syndrome.
Yoon HA; Nakouzi A; Chang CC; Kuniholm MH; Carreño LJ; Wang T; Ndung'u T; Lewin SR; French MA; Pirofski LA
J Infect Dis; 2019 Jan; 219(3):420-428. PubMed ID: 30010905
[TBL] [Abstract][Full Text] [Related]
14. Cryptococcus neoformans ex vivo capsule size is associated with intracranial pressure and host immune response in HIV-associated cryptococcal meningitis.
Robertson EJ; Najjuka G; Rolfes MA; Akampurira A; Jain N; Anantharanjit J; von Hohenberg M; Tassieri M; Carlsson A; Meya DB; Harrison TS; Fries BC; Boulware DR; Bicanic T
J Infect Dis; 2014 Jan; 209(1):74-82. PubMed ID: 23945372
[TBL] [Abstract][Full Text] [Related]
15. Significance of antibody detection in the diagnosis of cryptococcal meningitis.
Patil SA; Katyayani S; Arvind N
J Immunoassay Immunochem; 2012; 33(2):140-8. PubMed ID: 22471604
[TBL] [Abstract][Full Text] [Related]
16. Heat shock protein 70 (hsp70) as a major target of the antibody response in patients with pulmonary cryptococcosis.
Kakeya H; Udono H; Maesaki S; Sasaki E; Kawamura S; Hossain MA; Yamamoto Y; Sawai T; Fukuda M; Mitsutake K; Miyazaki Y; Tomono K; Tashiro T; Nakayama E; Kohno S
Clin Exp Immunol; 1999 Mar; 115(3):485-90. PubMed ID: 10193422
[TBL] [Abstract][Full Text] [Related]
17. Cryptococcus neoformans- and Cryptococcus gattii-specific IgG, IgA and IgM differ among children and adults with and without cryptococcosis from Colombia.
Becerra-Álvarez P; Escandón P; Lizarazo J; Quirós-Gómez Ó; Firacative C
Med Mycol; 2022 Sep; 60(9):. PubMed ID: 36066645
[TBL] [Abstract][Full Text] [Related]
18. Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection.
Casadevall A; Mukherjee J; Devi SJ; Schneerson R; Robbins JB; Scharff MD
J Infect Dis; 1992 Jun; 165(6):1086-93. PubMed ID: 1583327
[TBL] [Abstract][Full Text] [Related]
19. The Mouse Inhalation Model of
Mukaremera L; McDonald TR; Nielsen JN; Molenaar CJ; Akampurira A; Schutz C; Taseera K; Muzoora C; Meintjes G; Meya DB; Boulware DR; Nielsen K
Infect Immun; 2019 Mar; 87(5):. PubMed ID: 30833336
[TBL] [Abstract][Full Text] [Related]
20. Relapsing meningitis caused by persistent cryptococcal antigens and immune reconstitution after the initiation of highly active antiretroviral therapy.
Boelaert JR; Goddeeris KH; Vanopdenbosch LJ; Casselman JW
AIDS; 2004 May; 18(8):1223-4. PubMed ID: 15166545
[No Abstract] [Full Text] [Related]
[Next] [New Search]
